News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Comprehensive molecular profiling of squamous non-small cell lung cancer
Non-Small Cell Lung Cancer/LinkedIn
Jan 29, 2025, 08:15

Comprehensive molecular profiling of squamous non-small cell lung cancer

Akhil Santhosh, Medical Oncologist at AIIMS Delhi, shared an article by Joshua E. Reuss on X:

“Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking – Lung Cancer.

Should look out for MET and EGFR alterations.”

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking.

Authors: Joshua E. Reuss, et al.

Comprehensive molecular profiling of squamous non-small cell lung cancer

AIIMS cancer EGFR fight against cancer Global fight against cancer Joshua E. Reuss Lung cancer MET molecular profiling non small cell lung cancer OncoDaily Oncology
Special Coverage
Science
Jan 29, 2025, 08:15
Comprehensive molecular profiling of squamous non-small cell lung cancer
Blog
Jan 29, 2025, 08:13
Amani Masaule: Have you ever thought about the journey of a cancer patient?
Blog
Jan 29, 2025, 08:10
Harriet Cabelly: Introducing My New Book - "Light Through Darkness: Miracles Along My Cancer Journey"
Blog
Jan 29, 2025, 08:07
Enrique Grande: The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity
Blog
Jan 29, 2025, 08:05
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer
Blog
Jan 29, 2025, 08:02
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma
Blog
Jan 29, 2025, 07:56
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Blog
Jan 29, 2025, 07:53
Krishan Jethwa: Prognostic significance of detectable ctDNA in the NEO-trial
Blog
Jan 29, 2025, 07:52
Kelsey Pan: Encorafenib, cetuximab and nivolumab in patients with BRAF V600E mutated mCRC
Blog
Jan 29, 2025, 07:48
How do copy no. deletions in STK11, KEAP1 and SMARCA4 impact outcomes in NSCLC?
Blog
Jan 29, 2025, 07:46
Krishan Jethwa: Highlighting comparison of OPRA vs AIO-12
Blog
Jan 29, 2025, 07:45
Eric Singhi: Reducing IRRs with IV amivantamab in EGFR+ mNSCLC post osimertinib/chemotherapy